AB

Abbvie

ABBV
NYSEHealth Care

Recent Patents

abbv
1 year ago

Filed a patent for "methods of treating human immunodeficiency virus (hiv) disease" on Tue, August 15, 2023

New US Patent
abbv
1 year ago

Filed a patent for "methods of treating human immunodeficiency virus (hiv) disease" on Wed, October 18, 2023

New US Patent
abbv
1 year ago

Filed a patent for "compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism" on Thu, February 13, 2025

New US Patent
abbv
1 year ago

Filed a patent for "nasal stimulation devices and methods" on Thu, January 30, 2025

New US Patent
abbv
over 1 year ago

Filed a patent for "modulators of the integrated stress pathway" on Sun, April 28, 2024

New US Patent
abbv
over 1 year ago

Filed a patent for "wearable automatic injection device for controlled administration of therapeutic agents" on Thu, January 16, 2025

New US Patent
abbv
over 1 year ago

Filed a patent for "injection device" on Thu, January 9, 2025

New US Patent
abbv
over 1 year ago

Filed a patent for "enzyme compositions with reduced viral and microbial contamination" on Thu, December 26, 2024

New US Patent
abbv
over 1 year ago

Filed a patent for "time released biodegradable or bioerodible microspheres or microparticles suspended in a solidifying depot-forming injectable drug formulation" on Thu, December 26, 2024

New US Patent
abbv
over 1 year ago

Filed a patent for "ketorolac compositions for corneal wound healing" on Thu, January 2, 2025

New US Patent
abbv
over 1 year ago

Filed a patent for "intraocular implant with high loading of a prostamide" on Thu, January 2, 2025

New US Patent
abbv
over 1 year ago

Filed a patent for "assay for evaluating tau propagation" on Thu, March 16, 2023

New US Patent
abbv
over 1 year ago

Filed a patent for "methods of treatment using anti-c-met antibody drug conjugates" on Tue, May 23, 2023

New US Patent
abbv
over 1 year ago

Filed a patent for "anti-human cd33 bet degrader antibody-drug conjugates" on Thu, June 1, 2023

New US Patent
abbv
over 1 year ago

Filed a patent for "anti-human cd33 bet degrader antibody-drug conjugates" on Thu, September 21, 2023

New US Patent
abbv
over 1 year ago

Filed a patent for "methods of treatment using anti-c-met antibody drug conjugates" on Tue, February 20, 2024

New US Patent
abbv
over 1 year ago

Filed a patent for "devices for injection and dosing" on Thu, December 12, 2024

New US Patent
abbv
over 1 year ago

Filed a patent for "alpha-2-adrenergic receptor agonists for reducing redness and increasing whiteness in eyes and other ophthalmic purposes" on Thu, November 28, 2024

New US Patent
abbv
over 1 year ago

Filed a patent for "3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof" on Thu, December 5, 2024

New US Patent
abbv
over 1 year ago

Filed a patent for "cooling devices with flexible sensors" on Thu, December 5, 2024

New US Patent
abbv
over 1 year ago

Filed a patent for "methods of treating vitiligo with upadacitinib" on Tue, May 23, 2023

New US Patent
abbv
over 1 year ago

Filed a patent for "methods of treating vitiligo with upadacitinib" on Wed, October 11, 2023

New US Patent
abbv
over 1 year ago

Filed a patent for "dosing regimens for use in preventing relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation with venetoclax in combination with azacitidine" on Thu, April 6, 2023

New US Patent
abbv
over 1 year ago

Filed a patent for "nasal stimulation devices and methods" on Thu, October 31, 2024

New US Patent
abbv
over 1 year ago

Filed a patent for "prostamide-containing intraocular implant" on Thu, October 31, 2024

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...